Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System by Poglitsch, Marko, Domenig, Oliver, Schwager, Cornelia, Stranner, Stefan, Peball, Bernhard, Janzek, Evelyne, Wagner, Bettina, Jungwirth, Helmut, Loibner, Hans, Schuster, Manfred

Get full text

Microheterogeneity of therapeutic monoclonal antibodies is governed by changes in the surface charge of the protein by Hintersteiner, Beate, Lingg, Nico, Janzek, Evelyne, Mutschlechner, Oliver, Loibner, Hans, Jungbauer, Alois

Get full text

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO by Mueller, Ina, Ehlert, Karoline, Endres, Stefanie, Pill, Lena, Siebert, Nikolai, Kietz, Silke, Brock, Penelope, Garaventa, Alberto, Valteau-Couanet, Dominique, Janzek, Evelyne, Hosten, Norbert, Zinke, Andreas, Barthlen, Winfried, Varol, Emine, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.

Get full text

Abstract CT410: Immune activation, clinical response and survival following long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 in high-risk neuro... by Lode, Holger, Jensen, Christian, Siebert, Nikolai, Kietz, Silke, Ehlert, Karoline, Müller, Ina, Ladenstein, Ruth, Janzek, Evelyne, Loibner, Hans

Get full text

Abstract 2858: Binding characteristics of the immunocytokine hu14.18-IL2 and induction of human effector functions as anticipated mode of action by Loibner, Hans, Schuster, Manfred, Janzek, Evelyne, Stranner, Stefan, Peball, Bernhard, Wiederkum, Susanne, Mutschlechner, Oliver, Siebert, Nikolai, Lode, Holger

Get full text

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD 2 antibody ch14.18/CHO by Mueller, Ina, Ehlert, Karoline, Endres, Stefanie, Pill, Lena, Siebert, Nikolai, Kietz, Silke, Brock, Penelope, Garaventa, Alberto, Valteau-Couanet, Dominique, Janzek, Evelyne, Hosten, Norbert, Zinke, Andreas, Barthlen, Winfried, Varol, Emine, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N

Get full text

In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system by Schuster, Manfred, Jost, Wolfgang, Mudde, Geert C., Wiederkum, Susanne, Schwager, Cornelia, Janzek, Evelyne, Altmann, Friedrich, Stadlmann, Johannes, Stemmer, Christian, Gorr, Gilbert

Get full text

Abstract A032: Immunotherapy with ch14.18/CHO in combination with IL2 is active and effective in high-risk relapsed/refractory neuroblastoma patients by Lode, Holger N., Valteau-Couanet, Dominique, Garaventa, Alberto, Gray, Juliet, Castel, Victoria, Yaniv, Isaac, Siebert, Nikolai, Jensen, Christian, Endres, Stefanie, Pill, Lena, Eger, Christin, Seidel, Diana, Jüttner, Madlen, Kietz, Silke, Ehlert, Karoline, Janzek, Evelyne, Manzitti, Carla, Müller, Ina, Loibner, Hans, Ladenstein, Ruth

Get full text

Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients by Lode, Holger, Siebert, Nikolai, Kietz, Silke, Müller, Ina, Schuster, Manfred, Janzek, Evelyne, Wiederkum, Susanne, Mutschlechner, Oliver, Loibner, Hans

Get full text

Enzymic synthesis and comparative biological evaluation of a phosphonate analog of the lipid A precursor by Scholz, Dieter, Bednarik, Karl, Ehn, Gerald, Neruda, Wolfgang, Janzek, Evelyne, Loibner, Hans, Briner, Karin, Vasella, Andrea

Get full text

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO by Mueller, Ina, Ehlert, Karoline, Endres, Stefanie, Pill, Lena, Siebert, Nikolai, Kietz, Silke, Brock, Penelope, Garaventa, Alberto, Valteau-Couanet, Dominique, Janzek, Evelyne, Hosten, Norbert, Zinke, Andreas, Barthlen, Winfried, Varol, Emine, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.

Get full text